查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1820397

2025 年至 2033 年氧气治疗市场规模、份额、趋势及预测（按产品、应用、最终用途和地区划分）

Oxygen Therapy Market Size, Share, Trends and Forecast by Product, Application, End Use, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 148 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球氧气治疗市场规模达201.5亿美元。预计到2033年，该市场规模将达到343.7亿美元，2025年至2033年的复合年增长率为6.05%。目前，北美占据市场主导地位，2024年的市占率将超过37.9%。由于呼吸系统疾病发病率上升以及人们对居家医疗照护的日益偏好，全球氧气治疗市场正在迅速扩张。影响市场的显着趋势包括便携式和可穿戴式供氧系统的进步、智慧技术的融入以及更加重视根据患者个体需求量身定制治疗方案。

氧气治疗市场的主要驱动力在于慢性阻塞性肺病 (COPD) 和气喘等疾病的发病率不断上升，这些疾病需要长期氧气治疗。例如，艾默生开发了 ASCO(TM) 588 系列固定式氧气浓缩器歧管，作为呼吸治疗布局的完整套件，有助于加快产品上市时间。此外，增强型便携式氧气设备提供行动支持，可轻鬆安装以满足家庭医疗保健需求，从而促进市场成长。此外，老年人口比例的上升导致呼吸系统疾病的发生率更高，这显着扩大了氧气治疗市场的份额。此外，人们对氧疗益处的认识不断加深，推动了全球氧气的使用，为市场提供了动力。此外，氧气浓缩器的持续创新增强了治疗效果，从而促进了市场成长。

美国占氧疗市场88.70%的份额。由于呼吸系统疾病（尤其是慢性阻塞性肺病）发病率的上升，该地区的氧气治疗需求正在不断增长。此外，医疗保健成本和保险的上涨也推动了氧气治疗需求，从而支撑了市场的成长。同时，家庭医疗保健技术的不断发展使患者能够在家中接受氧气治疗，这也刺激了市场需求。此外，大众对呼吸健康重要性的认识不断提高，促进了早期治疗，从而提升了市场份额。此外，由于空气污染加剧了呼吸系统疾病的负担，政府推出的慢性病管理措施也增加了氧气处方量，从而推动了市场的发展。

氧气治疗市场趋势：

家庭医疗保健趋势

大多数患者，尤其是老年人和慢性病患者，更倾向于在家中接受治疗，而不是去医院或疗养院。居家照护通常相对便宜，因为设备便携且易于管理，能够帮助患者保持活动能力和自由。 IMARCIMARC Group报告称，2023 年全球家庭医疗保健市场规模达到 3,922 亿美元。大多数慢性呼吸系统疾病，例如慢性阻塞性肺病 (COPD) 和肺纤维化，都需要长期氧气治疗。此外，家庭医疗保健被广泛用作管理所有疾病的工具，与治疗方案的依从性一致，并推动了氧气治疗市场的成长。

呼吸系统疾病盛行率不断上升

根据世界卫生组织 (WHO) 网站上 2023 年发表的一篇文章，慢性阻塞性肺病 (COPD) 是全球第三大死因，2019 年造成 323 万人死亡。氧气治疗在治疗 COPD、气喘、间质性肺病或肺炎等常见疾病的症状时至关重要。这是因为呼吸系统疾病危害极大，只有持续治疗才能帮助有此类疾病的患者。此外，氧气治疗对于为慢性呼吸系统疾病患者提供充足的血液氧气至关重要，因此推动了市场成长。

人口老化

老年患者经常遭受呼吸系统疾病的困扰，包括慢性阻塞性肺病 (COPD)、肺气肿以及肺炎，目前唯一已知的治疗方法是氧气治疗。老年人的呼吸系统疾病也可能伴随高血压、心臟病和糖尿病等其他疾病，这些疾病会加重呼吸道疾病，因此氧气治疗不可或缺。老年人的免疫系统较弱，容易引发多种感染，最终导致严重的呼吸系统疾病。由于免疫系统较弱，老年人也会罹患严重的呼吸系统疾病。国际货币基金组织 (IMF) 电子图书馆网站上发表的一篇文章显示，到 2050 年，全球 80 岁及以上人口的比例预计将增长四倍，达到近 5%。

新兴发展重塑市场格局

受多种同步发展的影响，市场正稳定成长。一个主要因素是慢性呼吸系统疾病发生率的上升，尤其是慢性阻塞性肺病 (COPD)、睡眠呼吸中止症和肺纤维化。美国的一项产业研究强调了睡眠呼吸中止症的普遍性，该研究显示，30 至 70 岁的成年人中 26% 至少患有轻度阻塞性睡眠呼吸中止症，而 10% 患有中度至重度阻塞性睡眠呼吸中止症。这持续推动了对长期氧气支持的需求。此外，製造商正专注于便携式和穿戴式氧气输送系统。紧凑型氧气浓缩器和轻巧的可穿戴设备使用户能够保持移动性，使家庭和旅行使用更加便捷。此外，随着临床医生和设备製造商寻求根据个人需求客製化氧气流量和输送模式，个人化氧疗正日益受到关注。同时，监管部门批准的数量有所增加，尤其是针对便携式和智慧氧气输送设备的批准数量，这既反映了安全性的提高，也反映了市场信心的增强。此外，设备製造商、医院和家庭医疗保健提供者之间的策略合作进一步支持了产品创新以及在临床和非临床环境中的更广泛应用。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球氧气治疗市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 氧源设备
    • 关键部分
      • 氧气瓶
      • 氧气浓缩器
      • 液态氧装置
      • PAP 设备
  • 氧气输送装置
    • 关键部分
      • 氧气面罩
      • 鼻导管
      • 文丘里面罩
      • 非循环呼吸器面罩
      • 袋阀口罩
      • CPAP面罩
      • 其他的

第七章：市场区隔：依应用

  • 慢性阻塞性肺臟疾病
  • 气喘
  • 阻塞性睡眠呼吸中止症
  • 呼吸窘迫症候群
  • 囊肿纤维化
  • 肺炎
  • 其他的

第 8 章：市场区隔：最终用途别

  • 家庭医疗保健
  • 医院

第九章：市场细分：依地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 10 章：SWOT 分析

第 11 章：价值链分析

第 12 章：波特五力分析

第十三章：价格分析

第 14 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Allied Healthcare Products Inc.
    • Becton Dickinson and Company
    • DeVilbiss Healthcare LLC (Drive Medical Inc.)
    • Fisher & Paykel Healthcare Limited
    • General Electric Company
    • Getinge AB
    • Hersill SL
    • Invacare Corporation
    • Koninklijke Philips NV
    • Smiths Group plc
    • Tecno-Gaz SpA
    • Teleflex Incorporated
Product Code: SR112025A3847

The global oxygen therapy market size was valued at USD 20.15 Billion in 2024. The market is projected to reach USD 34.37 Billion by 2033, exhibiting a CAGR of 6.05% from 2025-2033. North America currently dominates the market, holding a market share of over 37.9% in 2024. The oxygen therapy market worldwide is expanding rapidly due to a higher incidence of respiratory conditions and a growing preference for home-based medical care. Notable trends shaping the market include advances in portable and wearable oxygen delivery systems, the incorporation of smart technologies, and greater emphasis on tailoring therapy to individual patient needs.

The oxygen therapy market is primarily driven by the increasing incidence of diseases such as chronic obstructive pulmonary disease (COPD) and asthma, which require long-term oxygen therapy. For instance, Emerson developed the ASCO(TM) Series 588 Stationary Oxygen Concentrator Manifold as a complete package for respiratory therapy layouts and to help expedite time to market. In addition, the enhanced portable oxygen devices give mobile support, which allows easy installation for in-home healthcare needs, aiding the market growth. Moreover, the percentage of the aging population group triggers respiratory illnesses more frequently, which is significantly expanding the oxygen therapy market share. Besides this, the increased understanding of the benefits associated with oxygen therapy is boosting the use of oxygen across the globe, providing an impetus to the market. Apart from this, the continuous innovation in oxygen concentrators enhances the impact of treatment, thereby catalyzing the market growth.

The United States holds a share of 88.70% in the oxygen therapy market. The demand in the region is expanding, due to the increasing incidence of diseases of the respiratory system, especially COPD. Moreover, the increase in health care costs and insurance is driving the demand for oxygen therapies, supporting the market growth. Concurrently, continuous developments in home healthcare technology make it possible for patients to receive oxygen therapy at home, which is fueling the market demand. Also, higher public awareness of how respiratory health is valuable promotes early treatment, thus strengthening the market share. Apart from this, the government initiatives for chronic disease management increase oxygen prescription, as air pollution increases the burden of respiratory diseases, thereby propelling the market forward.

Oxygen Therapy Market Trends:

Home healthcare trends

Most patients especially the elderly and those with chronic diseases prefer to be treated at home instead of in hospitals or nursing homes. At-home care is often relatively cheaper as the devices are portable, and easy to manage, allowing the patient to maintain their mobility and freedom. The IMARC Group reports that the global home healthcare market reached USD 392.2 Billion in 2023. Most chronic respiratory conditions such as COPD and pulmonary fibrosis require oxygen therapy for the long term. Additionally, home healthcare is widely used as a tool for the management of all illnesses, aligning with the compliance of treatment regimens and impelling the oxygen therapy market growth.

Increasing prevalence of respiratory diseases

According to an article published on the website of the World Health Organization (WHO) in 2023, the third leading cause of death worldwide is COPD, causing 3.23 million deaths in 2019. Oxygen therapy is extremely necessary during the treatment of symptoms of quite common diseases such as COPD, asthma, interstitial lung disease, or pneumonia. This is because respiratory ailments are injurious, and only extended treatment can help those patients, who have such conditions. Furthermore, oxygen therapy is of great importance in the prescription of sufficient oxygen in the blood for chronic respiratory illnesses, thus impelling market growth.

Aging population

The elderly patients suffer frequent respiratory conditions including COPD, emphysema as well as pneumonia, and the only known cure is the use of oxygen therapy. Respiratory diseases in old people may also be accompanied by other diseases such as hypertension, heart disease, and diabetes, which worsen respiratory diseases and therefore make oxygen therapy mandatory. Features characteristic of elders are the immune system that draws several infections leading to major respiratory illnesses. The elders also suffer from severe respiratory illnesses due to low immune system strength. An article published on the website of the International Monetary Fund (IMF) eLibrary shows that by 2050 the global share of people aged 80 and older is expected to quadruple to almost 5%.

Emerging Developments Reshaping the Market Landscape

The market is witnessing steady growth, influenced by several concurrent developments. A primary factor is the rising incidence of chronic respiratory diseases, particularly COPD, sleep apnea, and pulmonary fibrosis. Highlighting the widespread nature of sleep apnea, an industry study in the United States revealed that 26% of adults aged 30 to 70 exhibited at least mild obstructive sleep apnea, while 10% were found to have moderate to severe forms of the condition. This continues to drive demand for long-term oxygen support. Alongside this, manufacturers are focusing on portable and wearable oxygen delivery systems. Compact oxygen concentrators and lightweight wearable units allow users to maintain mobility, making home and travel use more convenient. In addition to this, personalized oxygen therapy is gaining attention as clinicians and device manufacturers seek to tailor oxygen flow rates and delivery modes to individual needs. Simultaneously, an uptick in regulatory approvals, particularly for portable and smart oxygen delivery devices, reflects both safety advancements and growing market confidence. Also, strategic collaborations between device manufacturers, hospitals, and home healthcare providers have further supported product innovation and broader adoption across both clinical and non-clinical settings.

Oxygen Therapy Industry Segmentation:

Analysis by Product:

  • Oxygen Source Equipment
    • Oxygen Cylinders
    • Oxygen Concentrators
    • Liquid Oxygen Devices
    • PAP Devices
  • Oxygen Delivery Devices
    • Oxygen Masks
    • Nasal Cannula
    • Venturi Masks
    • Non-rebreather Masks
    • Bag Valve Masks
    • CPAP Masks
    • Others

Oxygen source equipment stands as the largest component in 2024, holding around 57.6% of the market. It is essential for oxygen treatment because it supplies patients with the oxygen they require. Without these devices, it would be hard to provide oxygen to patients in need, making them market-essential. These devices are used in various contexts, including hospitals, clinics, and home healthcare facilities. Their adaptability and requirement in many healthcare settings are driving their strong adoption. Moreover, continuous advancements and improvements in oxygen source equipment, such as portable and lightweight designs, enhanced efficiency, and user-friendly features, are transforming the oxygen therapy market overview.

Analysis by Application:

  • Chronic Obstructive Pulmonary Disease
  • Asthma
  • Obstructive Sleep Apnea
  • Respiratory Distress Syndrome
  • Cystic Fibrosis
  • Pneumonia
  • Others

Chronic obstructive pulmonary disease (COPD) leads the market with around 32.9% of the market share in 2024. The high incidence of COPD directly corresponds to a large patient population requiring oxygen therapy, making it the most common application area. COPD is a progressive and chronic ailment that usually worsens with time, and strongly demands long-term care procedures and treatment. Patients with COPD may require continuous or intermittent oxygen therapy to control symptoms and maintain their quality of life. Oxygen treatment alleviates respiratory difficulties and severe shortness of breath, making it an essential part of COPD management, thereby positively influencing the oxygen therapy market insights.

Analysis by End Use:

  • Home Healthcare
  • Hospitals

Home healthcare holds the largest market with around 32% of the market share in 2024. Many patients prefer to be treated at home rather than in hospitals or clinics for treatment. Home healthcare allows patients to continue their routines and stay in familiar environments, which benefits their overall well-being and satisfaction with the services. Additionally, home healthcare is more cost-effective than inpatient treatment in general. It eliminates long hospitalizations, reduces health costs, and relieves the burden on hospitals. This cost-saving is attractive to patients and healthcare providers. In portable oxygen concentrators and other home-use oxygen delivery systems, medical technology has made oxygen therapy more manageable for patients at home. Many of these gadgets have become easier to use, faster, and lightweight enhancing their application in the homes.

Analysis by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of 37.9%. There is a high incidence of respiratory diseases in the region including COPD, asthma, and sleep apnea due to several factors including aging, smoking, and pollution. The availability of sophisticated technologies, easy access to these technologies, and robust reimbursement strategies all contribute to the growth of the market. In addition, the growth of home care and portable and easy-to-use oxygen therapy devices enhance the ability of patients to manage their diseases from their homes. Furthermore, important players in this area are interested in increasing the storage capacities of oxygen. For instance, in 2024 Chart Industries announced the grand opening of its jumbo cryogenic tank manufacturing facility in Theodore, Alabama.

Key Regional Takeaways:

United States Oxygen Therapy Market Analysis

The adoption of oxygen therapy is witnessing a notable rise, fueled by the increasing investments in healthcare systems. For instance, in 2024, US healthcare companies securing venture capital deals over USD 15 Million saw a surge in investments, benefiting oxygen therapy advancements. This growth enhances access to innovative treatments, improving patient care and outcomes. As healthcare expenditures continue to grow, there is a greater emphasis on improving patient care, particularly for those with respiratory disorders. Enhanced healthcare infrastructures and access to advanced treatments have led to a higher demand for therapies such as oxygen therapy. The growing awareness of respiratory diseases and their impact on quality of life further drives the demand for these treatments. As the need for specialized care expands, healthcare facilities are better equipped to administer oxygen therapy, making it more accessible to patients in need. The increase in research funding and technological advancements in oxygen delivery systems are also contributing to the rise in therapy adoption, offering more efficient and comfortable solutions for individuals with respiratory challenges.

Europe Oxygen Therapy Market Analysis

Chronic diseases have been steadily rising, leading to an increasing need for oxygen therapy as a crucial part of patient management. The rising incidence of chronic conditions, such as COPD and heart diseases, requires long-term treatment, often involving oxygen support. The growing number of aging individuals, many of whom suffer from chronic ailments, has also played a significant role in the increased demand for oxygen therapy. For instance, in 2022, 2.9% of the EU population was aged 85 or older, with projections indicating this share will surpass 10% by 2050. This demographic shift highlights the increasing demand for oxygen therapy. Hospitals and medical care facilities are increasingly focusing on advanced therapies to support these patients. Moreover, the importance of oxygen therapy in improving their quality of life has been well recognized. New treatment protocols and greater access to home-based oxygen support devices contribute to the widespread adoption, further supporting oxygen therapy market growth. As healthcare institutions continue to prioritize the treatment of chronic conditions, the adoption of oxygen therapy has become a vital element in improving long-term patient outcomes, particularly for individuals with ongoing respiratory needs.

Asia Pacific Oxygen Therapy Market Analysis

Asthma cases are on the rise across the region, leading to a surge in the adoption of oxygen therapy. For instance, asthma affects over 35 million people in India, contributing significantly to the growing number of asthma patients. Oxygen therapy offers a promising solution to alleviate symptoms and improve the quality of life for asthma patients. As asthma becomes more prevalent, patients need proper and constant therapy because of the rising frequency of the disease. This has led to an increased need for oxygen therapy which is fundamental in managing asthma by reducing the extent or destructiveness of the symptoms. Furthermore, treatments like oxygen therapy, and increased revenues are tied to the fact that the healthcare system in the region pays more attention to respiratory disorders as its foundation is being built up. As a result of development and innovations in the field of health, delivery systems for oxygen have improved and there is therefore increased capacity of the patient to be well cared for in both the hospital and at home. Enhancing the patient base, advanced treatment solutions, and enhancing consciousness levels regarding asthma management are major factors augmenting the oxygen therapy market share across the region.

Latin America Oxygen Therapy Market Analysis

With rising disposable income, more individuals in Latin America are seeking home healthcare solutions, including oxygen therapy. For instance, between 2021 and 2040, Latin America's total disposable income is projected to rise by nearly 60%, driven by regional disparities narrowing and technological advancements. This growth boosts demand for home healthcare services by enhancing affordability and accessibility. This economic growth is enabling a broader section of the population to afford at-home treatments for chronic respiratory conditions. The ability to manage health from the comfort of home is becoming more appealing, especially as the quality of healthcare services improves. Patients with respiratory illnesses prefer using client-transportable oxygen concentration equipment, which can be relocated in the home setting. Common hospital-based treatments are much more convenient and economical. The increased affordability of oxygen therapy as a home healthcare product along with easier access to healthcare products has played a vital part in the advancement of the therapy in the region. Rising disposable income is therefore central to the home health care oxygen therapy industry, thus driving the market forward.

Middle East and Africa Oxygen Therapy Market Analysis

Healthcare facilities in the region have expanded significantly, improving access to critical care and oxygen therapy services. According to the Dubai Healthcare City Authority report, by 2022, Dubai saw a significant expansion in healthcare facilities, with 4,482 private medical establishments, including 56 hospitals, and 55,208 licensed professionals. The Dubai Health Authority forecasts a 10-15% growth in medical professionals and a 3-6% rise in facilities through 2023 and beyond. The increased availability of medical centers and specialized healthcare providers has facilitated easier access to therapies for individuals with respiratory needs. With an emphasis on upgrading healthcare infrastructure, there has been a significant push to enhance treatment options, including oxygen therapy, for patients with respiratory disorders. The expansion of healthcare facilities ensures that more people can access essential services, such as oxygen therapy, which is vital for those suffering from chronic respiratory conditions. This development is creating a more favorable environment for the growth of oxygen therapy adoption across the region.

Competitive Landscape:

The global oxygen therapy market is highly saturated, and companies are striving to maintain their position through innovation of products, strategic partnerships, and new product launches. One of the major trends is the creation of portable and wearable oxygen delivery devices for meeting the growing home healthcare equipment market. Additionally, to enhance the efficiency, flexibility, and portability of a device, companies are increasingly underlining the significance of research and development (R&D). Other factors that are influencing the market include the approval of regulations for advanced technology and developing collaborations with the healthcare sector. Also, through acquisitions and mergers, competition is being pressed through market consolidation and improvements in product offerings. They point to the emergence of new respiratory ailments on the market and the shift towards home-based solutions.

The report provides a comprehensive analysis of the competitive landscape in the oxygen therapy market with detailed profiles of all major companies, including:

  • Allied Healthcare Products Inc.
  • Becton Dickinson and Company
  • DeVilbiss Healthcare LLC (Drive Medical Inc.)
  • Fisher & Paykel Healthcare Limited
  • General Electric Company
  • Getinge AB
  • Hersill SL
  • Invacare Corporation
  • Koninklijke Philips N.V
  • Smiths Group plc
  • Tecno-Gaz S.p.A.
  • Teleflex Incorporated

Key Questions Answered in This Report

  • 1.How big is the oxygen therapy market?
  • 2.What is the future outlook of the oxygen therapy market?
  • 3.What are the key factors driving the oxygen therapy market?
  • 4.Which region accounts for the largest oxygen therapy market share?
  • 5.Which are the leading companies in the global oxygen therapy market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Oxygen Therapy Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Oxygen Source Equipment
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 Oxygen Cylinders
      • 6.1.2.2 Oxygen Concentrators
      • 6.1.2.3 Liquid Oxygen Devices
      • 6.1.2.4 PAP Devices
    • 6.1.3 Market Forecast
  • 6.2 Oxygen Delivery Devices
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Oxygen Masks
      • 6.2.2.2 Nasal Cannula
      • 6.2.2.3 Venturi Masks
      • 6.2.2.4 Non-rebreather Masks
      • 6.2.2.5 Bag Valve Masks
      • 6.2.2.6 CPAP Masks
      • 6.2.2.7 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Chronic Obstructive Pulmonary Disease
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Asthma
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Obstructive Sleep Apnea
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Respiratory Distress Syndrome
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Cystic Fibrosis
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Pneumonia
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Others
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast

8 Market Breakup by End Use

  • 8.1 Home Healthcare
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Hospitals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Allied Healthcare Products Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Becton Dickinson and Company
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 DeVilbiss Healthcare LLC (Drive Medical Inc.)
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
    • 14.3.4 Fisher & Paykel Healthcare Limited
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
    • 14.3.5 General Electric Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Getinge AB
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Hersill SL
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 Invacare Corporation
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Koninklijke Philips N.V
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Smiths Group plc
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Tecno-Gaz S.p.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
    • 14.3.12 Teleflex Incorporated
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Oxygen Therapy Market: Major Drivers and Challenges
  • Figure 2: Global: Oxygen Therapy Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Oxygen Therapy Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Oxygen Therapy Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Oxygen Therapy Market: Breakup by Application (in %), 2024
  • Figure 6: Global: Oxygen Therapy Market: Breakup by End Use (in %), 2024
  • Figure 7: Global: Oxygen Therapy Market: Breakup by Region (in %), 2024
  • Figure 8: Global: Oxygen Therapy (Oxygen Source Equipment) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 9: Global: Oxygen Therapy (Oxygen Source Equipment) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 10: Global: Oxygen Therapy (Oxygen Delivery Devices) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Oxygen Therapy (Oxygen Delivery Devices) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Oxygen Therapy (Chronic Obstructive Pulmonary Disease) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Oxygen Therapy (Asthma) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Oxygen Therapy (Asthma) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Oxygen Therapy (Obstructive Sleep Apnea) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Oxygen Therapy (Respiratory Distress Syndrome) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Oxygen Therapy (Cystic Fibrosis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Oxygen Therapy (Cystic Fibrosis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Oxygen Therapy (Pneumonia) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Oxygen Therapy (Pneumonia) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Oxygen Therapy (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Oxygen Therapy (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Oxygen Therapy (Home Healthcare) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Oxygen Therapy (Home Healthcare) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Oxygen Therapy (Hospitals) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Oxygen Therapy (Hospitals) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: North America: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: North America: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: United States: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: United States: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: Canada: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: Canada: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: Asia-Pacific: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: Asia-Pacific: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: China: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: China: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Japan: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Japan: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: India: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: India: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: South Korea: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: South Korea: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: Australia: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: Australia: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: Indonesia: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: Indonesia: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Others: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Others: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Europe: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Europe: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Germany: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Germany: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: France: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: France: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: United Kingdom: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: United Kingdom: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: Italy: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: Italy: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: Spain: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: Spain: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Russia: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Russia: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Others: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Others: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Latin America: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Latin America: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Brazil: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Brazil: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Mexico: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Mexico: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Others: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Others: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Middle East and Africa: Oxygen Therapy Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Middle East and Africa: Oxygen Therapy Market: Breakup by Country (in %), 2024
  • Figure 78: Middle East and Africa: Oxygen Therapy Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Global: Oxygen Therapy Industry: SWOT Analysis
  • Figure 80: Global: Oxygen Therapy Industry: Value Chain Analysis
  • Figure 81: Global: Oxygen Therapy Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Oxygen Therapy Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Oxygen Therapy Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Oxygen Therapy Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 4: Global: Oxygen Therapy Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 5: Global: Oxygen Therapy Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 6: Global: Oxygen Therapy Market: Competitive Structure
  • Table 7: Global: Oxygen Therapy Market: Key Players